Back to search

University of Crete (UOC)

Study of the neuroprotective and neurogenic actions of synthetic micromolecules in animal models of neurodegeneration

Abstract

dc:description

The adult mammalian brain possesses only a limited capacity for regeneration underpathological conditions that cause neuronal cell loss. However, the identification ofendogenous adult neural stem cells (aNSCs) that can proliferate and differentiate intofunctional neurons, unveil new intriguing possibilities towards restoration of brainfunction in case of a disease. aNSCs that lie mainly in the area of the dentate gyrus(DG) and in the subventricular zone (SVZ) are generated continuously and after theydifferentiate they get integrated to the existing circuit. These cells are responsive tointrinsic as well as external stimuli that affect their proliferation, their survival anddifferentiation. Such molecules are neurotrophins such as Nerve growth factor (NGF)and Brain derived neurotrophic factor (BDNF), as well as other growth factors such ashormones, which are also responsible for the patterning of nervous system duringdevelopment. Increasing neurogenesis with genetic or pharmacological manipulationimproves performance on various cognitive tasks while it has been recently shownthat there are specific types of functions of the DG that require the integration of newneurons such as pattern separation.Neurogenesis has been implicated in the pathophysiology of many neurodegenerativeand neuropsychiatric diseases. Alterations in neurogenesis have been observed invarious animal models of Alzheimer’s disease (AD) and have been linked toaccumulation of aβ amyloid and the development of neuroinflammation. On the otherhand stimulating adult hippocampal neurogenesis in these models either by means ofenvironmental enrichment, physical exercise or with pharmacological ways reducesamyloid pathology and improves cognitive function. Finally, adult neurogenesis isdramatically reduced during ageing and pharmacological agents that succeed torestore this decline were also effective to alleviate age-related memory deficits.Nevertheless, the clinical use of many molecules that have been shown to possessneurogenic properties is often problematic either because of their peptidic nature andtheir inability to cross the blood brain barrier or because they accompanied by offtarget adverse effects. For this reason, modern pharmacology is seeking of smalllipophilic molecules, which can mimic the actions of endogenous growth factors andshow good availability to the CNS as well as a good safety profile.In this study I have tested the neurogenic potential of two small molecules that belongto two different classes. One of them is fingolimod that has been approved for thetreatment of multiple sclerosis based on its ability to inhibit the egress of lymphocytesfrom lymphoid nodes, thus preventing its migration to the site of inflammation. It actsthrough activation of 5 subtypes of S1P receptors that belong to GPCR superfamilybut also as an intracellular messenger itself by regulating the expression of manygenes such as BDNF and other growth factors. However, S1P is also synthesized denovo in the CNS and S1P receptors are abundantly expressed in various regions andby a plethora of cell types in the CNS and the therapeutic effects of fingolimod havebeen tested for a wide range of CNS disorders, from neurodegenerative toneuropsychiatric conditions. Intrigued by the role of S1P during development but alsoin the maintenance of an intact nervous system I sought to determine if there are anyeffects of the -already in clinical use- agonist of S1PRs, fingolimod in regulation ofadult neurogenesis, which may contribute to its beneficial actions. My results showthat fingolimod can induce the proliferation and survival of adult hippocampalprogenitors in vivo and in vitro through activation of MAPK pathway and induction ofBDNF while it affects behavior that have been associated with the functional role ofadult neurogenesis.The other molecule that it was tested for its ability to induce adult neurogenesis was asynthetic analogue of the endogenous neurosteroid Dehydroepiandrosterone (DHEA),called BNN27. DHEA is synthesized in the periphery from the adrenal glands, butalso is synthesized de novo and secreted locally in the CNS in high concentration.DHEA has been shown to promote neuronal survival in various models ofneurodegeneration both in vivo and in vitro through divergent mechanisms and recentdata from our laboratory support the idea that some of these effects are mediated byactivation of NGF receptors (namely TrkA and p75NTR). However, the therapeutic useof DHEA is compromised because it widely affects the endocrine system by its ownor after conversion to other steroid hormones with possible tumorogenic action. Inparticular breast, endometrial, or prostate cancers have been associated withdisturbances on estrogens and androgen levels. Moreover the exact actions of DHEAcannot be distinguished from its metabolites. BNN27, has been developed bymodifications of DHEA structure in order to sustain its neuroprotective properties andavoid its further metabolism to androgens and estrogen. In this way, BNN27 lacks ofthe possible tumorogenic potential of the parent molecule, DHEA. In order to testwhether BNN27 could reproduce the anti-apoptotic effects of DHEA mediated byactivation of NGF receptors’ initiated signaling, we used cultures of sympatheticneurons that are known to be dependent on NGF for their survival as well as NGF nullmice embryos that exhibit massive cell death in the DRGs during the embryonicdevelopment. BNN27 was found efficient to reduce apoptosis due to NGF deprivationin both cases. Based on the neuroprotective actions of BNN27 I further sought toinvestigate if this molecule could support neurogenesis in the adult rodenthippocampus. BNN27, was not effective in inducing either proliferation or survival ofneural stem cells in the area in WT mice nor did it reversed neurogenic deficits in oldanimals. However, long-term administration of BNN27 ameliorated the neurogenicand cholinergic deficits in an animal model of amyloidosis, the 5XFAD mice, while italso reduced the amyloid burden.One the other part of this study I investigated the effects of microconically patternedsilicon substrates on the behavior of peripheral nervous system neurons and glialcells. Directed axonal outgrowth is necessary for nerve regeneration after an injurybut also in a broad range of applications in neuroscience such as construction ofmicrofluidic devices or neuronal interfaces. Among the factors that control theorientation of a regrowing axon are cellular cues and substrate topography. Based ontheir design, different topographies that have been tried so far to manipulate cellgrowth, migration, and differentiation of various cell types could be described by thefollowing geometries: continuous and discontinuous. These geometries could befurther classified based on the directionality as anisotropic, in which cues areprovided along a single axis or isotropic topographies which are uniform in alldirections, providing cues along multiple axesExamples of continuous topographiesare photolithographically fabricated grooved silicon substrates or electrospun polymerfibers at parallel or random orientation, while discontinuous geometries includesilicon or gold pillars or posts.Recently the bioengineering lab in IESL in FORTH developed and characterizedmicropatterned silicon culture substrates fabricated with the use ultra-fast pulsed laserstructuring. Upon increasing laser fluence surface roughness is also increased andacquires anisotropic geometrical characteristics. More specifically as we pass fromflat silicon to surfaces that display a higher degree of roughness, substrates arecomprised of microcones with elliptical shape and specific orientation. Surfaceroughness and wettablity of the micropatterned Si substrates, influence fibroblastadhesion as well as differentiation capacity of PC12 cells as response to NGF. At theframework of our collaboration we aim to investigate the effects of substrate oftopography in cell outgrowth and morphology of PNS populations.We showed thatcultured Schwann cells and sympathetic neurons of SCGs migrate or grow their axonsalong the major axis of microcones in parallel alignement. Moreover when Schwanncells are present they seem to drive the growing axons as it was revealed in coculturestudies of the populations examined as well as in whole DRG explant cultures aclassic model to study neurite outgrowth and Schwann cell migration.Our study demonstrates for first time that a discontinuous topography could drive thedirectional outgrowth of neurons and glial cells of the peripheral nervous system if itcontains at least a feature of anisotropy which is the elliptical shape of themicrocones. This distinct inherent property of our microstructures combined with theconductance of the material, provides a useful system to explore and control neuronalfunctions and subsequent network characteristics.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Efstathopoulos, Paschalis
  • Ευσταθόπουλος, Πασχάλης

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36484

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Efstathopoulos, Paschalis; Ευσταθόπουλος, Πασχάλης. Study of the neuroprotective and neurogenic actions of synthetic micromolecules in animal models of neurodegeneration. University of Crete (UOC), 2015. http://hdl.handle.net/10442/hedi/36484